Financials
Financial year 2025
François Reginster Nephrologie-Dialyse from Rixensart, company number BE0810296230, closed financial year 2025 with a result of € 138,749 after tax. For that financial year François Reginster Nephrologie-Dialyse recorded a gross margin of € 290,021 and equity of € 735,862. Compared with financial year 2024, the result moved from € 158,612 to € 138,749. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 17, 2025.
€ 735,862
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 138,749
▼ 13% vs 2024
Profit after tax over the fiscal year.
€ 356,220
▼ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 60,293 paid out
43 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 7,470
▼ 56% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 100
Supplier invoices still open on the last day of the fiscal year.
€ 23,853
▼ 22% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 232,600 | € 231,557 | € 279,775 | € 290,021 | ▲ 4% |
| Profit after taxes | € 131,066 | € 122,119 | € 158,612 | € 138,749 | ▼ 13% |
| Equity | € 582,326 | € 704,445 | € 657,407 | € 735,862 | ▲ 12% |
| Total debts | € 101,011 | € 31,899 | € 36,189 | € 23,953 | ▼ 34% |
| Cash | € 363,755 | € 453,424 | € 421,551 | € 356,220 | ▼ 15% |
| Retained profit | € 260,676 | € 382,795 | € 541,407 | € 619,862 | ▲ 14% |
| Dividend | € 101,066 | € 0 | € 0 | € 60,293 | |
| Bank debt | € 23,341 | € 14,092 | € 5,512 | € 0 | ▼ 100% |
| Balance sheet total | € 683,337 | € 736,343 | € 693,596 | € 791,015 | ▲ 14% |
Key figures of François Reginster Nephrologie-Dialyse, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to François Reginster Nephrologie-Dialyse?
What happened at François Reginster Nephrologie-Dialyse in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 138,749 (▼ 13% vs 2024). Source: NBB ↗
- New establishment in Rixensart. KBO
- François Reginster became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 131,066 profit in 2022 to € 138,749 profit in 2025.
Paid € 286,012 in corporate taxes since 2022.
Best year ever: 2024, with € 158,612 profit.
Paid out € 161,359 in dividends to the owners in total.
A new publication or filing at François Reginster Nephrologie-Dialyse? We notify you, reason included.
Follow François Reginster Nephrologie-DialyseDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind François Reginster Nephrologie-Dialyse is François Reginster.
Directors
According to the 2025 annual accounts
François Reginster
Director
since 2009
Establishments
Establishment units
Physical locations of this company
Avenue Jean de Luxembourg 19
1330 Rixensart
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0810.296.230
- VAT number
- BE 0810.296.230
- Registered office
- Avenue Jean de Luxembourg 19, 1330 Rixensart
- Names & denominations
- François Reginster Nephrologie-Dialyse · FRND
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 March 2009
- Peppol
- Active · Active since 8 Mar 2026